Search results for RMI2

73 hits were found for RMI2

# Family MCID Name MIFTS Score
1
BLM001 Bloom Syndrome 65 18.272
2
c FNC027 Fanconi Anemia, Complementation Group a 81 9.760
3
MCR365 Microcephaly, Growth Restriction, and Increased Sister Chromatid Exchange 2 27 9.407
4
P RTH006 Rothmund-Thomson Syndrome, Type 2 67 8.442
5
BLL001 Baller-Gerold Syndrome 58 8.442
6
RPD002 Rapadilino Syndrome 47 8.442
7
OVR013 Ovarian Mucinous Cystadenocarcinoma 32 8.442
8
MLG033 Malignant Ovarian Cyst 20 8.442
9
ATS010 Autosomal Recessive Disease 42 3.358
10
c FNC042 Fanconi Anemia, Complementation Group D2 54 2.554
11
P LNG064 Lung Cancer Susceptibility 3 70 2.471
12
P ADN016 Adenocarcinoma 63 2.170
13
P END044 Endometriosis 62 2.014
14
OVR094 Ovarian Epithelial Cancer 39 2.014
15
CRV035 Cervical Cancer 73 1.928
16
CRV038 Cervical Squamous Cell Carcinoma 58 1.928
17
SQM006 Squamous Cell Carcinoma 60 1.928
18
P PRS040 Prostate Cancer 95 1.502
19
P FLL037 Follicular Lymphoma 74 1.344
20
PLS025 Plasmablastic Lymphoma 56 1.275
21
P BRS047 Breast Cancer 98 1.209
22
P LNG032 Lung Cancer 98 1.152
23
c FNC029 Fanconi Anemia, Complementation Group I 56 1.077
24
P PNC035 Pancreatic Cancer 86 1.077
25
c BDY007 Body Mass Index Quantitative Trait Locus 1 40 0.761
26
P PRG130 Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 1 54 0.761
27
P EXN002 Exanthem 58 0.761
28
DFC004 Deficiency Anemia 74 0.761
29
KRN002 Kearns-Sayre Syndrome 63 0.761
30
c PRG038 Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 2 49 0.761
31
c PRG040 Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 53 0.761
32
c CHR095 Chronic Progressive External Ophthalmoplegia 49 0.761
33
c PRG134 Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Recessive 5 22 0.761
34
SML031 Small Cell Carcinoma of the Bladder 46 0.601
35
GST103 Gastric Cancer, Hereditary Diffuse 68 0.521
36
HPT070 Hepatosplenic T-Cell Lymphoma 36 0.470
37
P BLD134 Bladder Cancer 79 0.425
38
END057 Endometrial Cancer 72 0.425
39
c GLM047 Glioma Susceptibility 3 33 0.425
40
c MSM022 Mismatch Repair Cancer Syndrome 1 70 0.425
41
c GLM025 Glioma Susceptibility 2 30 0.425
42
c GLM043 Glioma Susceptibility 9 30 0.425
43
PLM173 Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and 46,xx Sex Reversal 34 0.425
44
P GLM040 Glioma Susceptibility 1 71 0.425
45
MNN043 Meningioma, Familial 79 0.425
46
SKN022 Skin Squamous Cell Carcinoma 54 0.425
47
P OLG002 Oligodendroglioma 66 0.425
48
LNG039 Lung Squamous Cell Carcinoma 57 0.425
49
PSD011 Pseudovascular Skin Squamous Cell Carcinoma 16 0.425
50
GLM045 Glioma 63 0.425
51
P OVR042 Ovarian Cancer 88 0.301
52
P TMR010 Tumor Predisposition Syndrome 67 0.301
53
c PLY162 Polyposis Syndrome, Hereditary Mixed, 1 60 0.301
54
c PRS097 Prostate Cancer, Hereditary, 1 39 0.301
55
P GST053 Gastric Cancer 83 0.301
56
c CLR087 Colorectal Cancer 12 34 0.301
57
c PRS070 Prostate Cancer, Hereditary, 12 22 0.301
58
c PRS071 Prostate Cancer, Hereditary, 13 25 0.301
59
c PRS117 Prostate Cancer, Hereditary, 11 24 0.301
60
c PRS114 Prostate Cancer, Hereditary, 2 33 0.301
61
ADN011 Adenoid Cystic Carcinoma 68 0.301
62
OVR062 Ovary Serous Adenocarcinoma 25 0.301
63
SML009 Small Intestine Adenocarcinoma 57 0.301
64
PRM126 Primary Peritoneal Carcinoma 62 0.301
65
GST040 Gastric Adenocarcinoma 67 0.301
66
ADN089 Adenosquamous Lung Carcinoma 49 0.301
67
END041 Endometrial Adenocarcinoma 64 0.301
68
CLN015 Colon Adenocarcinoma 65 0.301
69
LNG012 Lung Occult Squamous Cell Carcinoma 20 0.301
70
BRN015 Bronchiolo-Alveolar Adenocarcinoma 55 0.301
71
LNG007 Lung Mixed Small Cell and Squamous Cell Carcinoma 21 0.301
72
LBL001 Lobular Neoplasia 55 0.301
73
PRS015 Prostate Signet Ring Cell Adenocarcinoma 25 0.301
Content
Loading form....